Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension. [electronic resource]
Publication details: Open heart Description: e000736 p. digitalISSN:- 2053-3624
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.